Severe acute respiratory syndrome (SARS) spread rapidly in 2002-2003, revealing just how vulnerable we might be to emerging diseases and how global transportation is critical to the spread of an epidemic.
Now, Vittoria Colizza and Alessandro Vespignani of Indiana University, Bloomington, USA and the Institute for Scientific Interchange Foundation, in Turin, Italy, and colleagues in France have developed a predictive model of the spread of emerging diseases based on actual travel and census data for more than three thousand urban areas in 220 countries. The model provides predictions of how likely an outbreak will be in each region and how widespread it might become. The research highlights just how the accuracy in predicting the spreading pattern of an epidemic can be related to clearly identifiable routes by which the disease could spread.
In order to assess the predictive power of their model, the researchers turned to the historical records of the global spread of the SARS virus. They evaluated the initial conditions before the disease had spread widely, based on the data for the arrival of the first patient who left mainland China for Hong Kong, and for the resulting outbreak there. They then simulated the likelihood that SARS would emerge in specific countries thereafter, as brought by infectious travelers. The simulated results fit very accurately with the actual pattern of the spread of SARS in 2002. Analysis of the results also identified possible paths of the virus' spread along the routes of commercial air travel, highlighting some preferred channels which may serve as epidemic pathways for the global spread of the disease.
"The presented computational approach shows that the integration of long-range mobility and demographic data provides epidemic models with a predictive power that can be consistently tested," the researchers explain. "This computational strategy can be therefore considered as a general tool in the analysis and forecast of the global spreading of emerging diseases."
BMC Medicine publishes original research articles, technical advances and study protocols in any area of medical science or clinical practice. BMC Medicine (ISSN 1741-7015) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, Scopus, CAS, Google Scholar and Thomson Scientific (ISI).
BioMed Central (http://www.biomedcentral.com) is a UK-based, independent online publishing house committed to providing open access to peer-reviewed biological and medical research. This commitment is based on the view that immediate free access to research and the ability to freely archive and reuse published information is essential to the rapid and efficient communication of science.
BioMed Central currently publishes over 180 journals across biology and medicine. In addition to open-access original research, BioMed Central also publishes reviews, commentaries and other non-original-research content. Depending on the policies of the individual journal, this content may be open access or provided only to subscribers.
Charlotte Webber | alfa
Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital
New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
12.12.2017 | Physics and Astronomy
12.12.2017 | Earth Sciences
12.12.2017 | Power and Electrical Engineering